Anti-rejection
medicines are an important part of my kidney transplant care
NULOJIX® (belatacept) is a prescription medicine used to prevent transplant rejection in adults who have received a kidney transplant. NULOJIX, an intravenous infusion, is used with corticosteroids and certain other medicines.
It is not known if NULOJIX is safe and effective in children under 18 years old or in people who receive any other organ transplant.
NULOJIX should only be used in people who have been exposed to the Epstein-Barr virus.
Anti-rejection medicines are an important part of my kidney
transplant care
NULOJIX® (belatacept) is a prescription medicine used to prevent transplant rejection in adults who have received a kidney transplant. NULOJIX, an intravenous infusion, is used with corticosteroids and certain other medicines.
It is not known if NULOJIX is safe and effective in children under 18 years old or in people who receive any other organ transplant.
NULOJIX should only be used in people who have been exposed to the Epstein-Barr virus.
ModelPortrayal
SELECTED IMPORTANT SAFETY INFORMATION
NULOJIX increases your risk of serious side effects, including
post-transplant lymphoproliferative disorder (PTLD), cancers other than PTLD,
progressive multifocal leukoencephalopathy (PML, a rare, serious brain infection), and
other serious infections caused by bacteria (including tuberculosis [TB]), viruses, or
fungi.
Please see below for additional Important Safety Information,
including bolded text.
Learn more about your kidney transplant—and NULOJIX
The following brochures are available for download to help you understand treatment with NULOJIX. You'll find information on what to expect during infusion and treatment. You'll also learn how NULOJIX can help you prevent kidney rejection.